SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging after a massive preliminary update revealing a record $60 billion order backlog and a significant jump in gross margins, which doubled initial guidance. The community is actively discussing a potential massive short squeeze, with many retail investors calling for a rapid price recovery while bears remain skeptical of management's long-term transparency.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is experiencing high momentum driven by geopolitical tensions in the Strait of Hormuz, which have constrained oil supply and pushed crude prices higher. The community is closely monitoring upcoming earnings and the potential impact of sustained energy premiums on the stock's valuation as institutional interest remains strong.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is seeing heightened volatility as investors debate the impact of AI on its long-term business model, with community sentiment split between those viewing the pullback as a generational buying opportunity and others concerned that AI tools could render the platform obsolete. Despite a strong balance sheet and robust user engagement, the stock remains under pressure as the market re-evaluates the company's shift toward prioritizing user growth over immediate monetization.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardano is drawing intense debate as community members weigh technical developments like the Van Rossem hard fork against concerns over network adoption and price volatility. While some investors see the current price levels as an accumulation opportunity, others are expressing frustration with leadership and market performance.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as investors aggressively accumulate shares and speculate on a potential short squeeze ahead of a highly anticipated second-quarter earnings update. The community remains focused on institutional buying patterns, strong commercial traction for Amtagvi, and the significant growth potential of the company's NSCLC pipeline.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending due to heightened geopolitical tensions and supply concerns stemming from renewed conflicts in the Middle East, particularly around the Strait of Hormuz. Market participants are actively discussing the impact of potential maritime blockades and infrastructure strikes on global energy prices, leading to significant volatility as traders weigh supply disruption risks against diplomatic mediation efforts.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is currently trending as investors weigh strong fundamental growth and potential margin expansion against geopolitical volatility in the Strait of Hormuz. While the community is actively debating the impact of energy supply disruptions on LNG exports and the stock's long-term valuation, sentiment remains divided between those expecting a significant breakout driven by record-breaking production capacity and those wary of ongoing short-term volatility and institutional positioning.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as retail investors engage in a heated debate over the stock's long-term valuation, with many citing the new AI-RAN partnership with Nvidia and upcoming earnings as catalysts for a potential reversal from recent lows. While bearish sentiment highlights concerns over telecom sector headwinds and disappointing price action, bullish participants are aggressively accumulating shares, viewing the current pullback as a deep-value opportunity for a stock they believe is central to future physical AI infrastructure.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing heightened volatility as traders weigh extreme swings in memory chip stocks and semiconductor sector sentiment against ongoing geopolitical tensions. The community remains deeply divided, with many actively debating whether to buy the dip during these sharp technical pullbacks or to position for further downside amid concerns regarding the sustainability of the AI infrastructure trade.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is experiencing significant volatility as investors weigh the company's aggressive pivot toward physical AI, robotics, and robotaxi commercialization against ongoing concerns regarding delivery growth and R&D spending. While some traders are bullish on its long-term potential as an AI-platform company, others remain skeptical, focusing on the stock's recent performance compared to domestic peers and macroeconomic headwinds in the Chinese market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026

Equity

Biopharma M&A has surged to $106 billion across 201 deals through early June 2026, putting the sector on track for its strongest full-year total since the 2019 pre-pandemic peak, CNBC reported.

Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development

Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development PR Newswire NEW YORK...

Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders?

Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders? Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 19, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders?

Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders? Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 12, 2026 Insiders may stand to receive...

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA PR Newswire NEW YORK, May 11, 2026 NEW YORK, May 11, 2026 /PRNewswire...

Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Centessa Pharmaceuticals plc (NasdaqGS: CNTA...

LLY Stock Jumps After Q1 Earnings Beat, 2026 Guidance Raised

LLY jumps after crushing Q1 estimates and raising 2026 outlook, powered by surging Mounjaro and Zepbound sales and strong global demand.

Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 12-Month High  - Still a Buy?

Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 52-Week High - Still a Buy...

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Short Interest Down 47.5% in April

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) was the recipient of a significant drop in short interest in the month of April. As of April 15th, there was short interest totaling 3,468,688 shares, a drop of 47.5% from the March 31st total of 6,607,633 shares. Based on...

Eli Lilly’s Been On An Acquisition Spree This Year – Here’s A Look At Its Major Deals 

Eli Lilly made several multi-billion dollar acquisitions in 2026, with a strong focus on strengthening its oncology pipeline.

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in the discovery, development, and delivery of medicines that are transformational for patients. It is primarily focused on developing orexin receptor agonists for neurological and neurodegenerative disorders, including programs targeting narcolepsy, idiopathic hypersomnia, and other neuropsychiatric conditions, as well as its early-stage LockBody immuno-oncology platform. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.

Centessa Pharmaceuticals plc - ADR

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.39	--	--	N/A
Q1 '26	-$0.41	--	--	N/A
Q4 '25	-$0.37	--	--	N/A
Q3 '25	-$0.39	-$0.41	-5.57%	MISSED
Q2 '25	-$0.33	-$0.38	-13.84%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

CNTACentessa Pharmaceuticals PLC - ADR

Upcoming Earnings: Q2 '26

Historical Earnings

Latest CNTA News